{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:16:17Z","timestamp":1777486577572,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"DOI":"10.7759\/cureus.76331","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T01:00:16Z","timestamp":1735088416000},"source":"Crossref","is-referenced-by-count":1,"title":["Incidental Diagnosis of Occult Maternal Malignancy With Routine Noninvasive Prenatal Testing During Pregnancy"],"prefix":"10.7759","author":[{"given":"Eniola R","family":"Ibirogba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E","family":"Tsimis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mili","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian C","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705345","article-title":"Sequencing of circulating cell-free DNA during pregnancy","volume":"379","author":"Bianchi DW","year":"2018","unstructured":"Bianchi DW, Chiu RW. Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med. 2018, 379:464-73. 10.1056\/NEJMra1705345","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2019.11.003","article-title":"Causes of aberrant non-invasive prenatal testing for aneuploidy: a systematic review","volume":"59","author":"Samura O","year":"2020","unstructured":"Samura O, Okamoto A. Causes of aberrant non-invasive prenatal testing for aneuploidy: a systematic review. Taiwan J Obstet Gynecol. 2020, 59:16-20. 10.1016\/j.tjog.2019.11.003","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5049","article-title":"Discordant non-invasive prenatal testing (NIPT) - a systematic review","volume":"37","author":"Hartwig TS","year":"2017","unstructured":"Hartwig TS, Ambye L, S\u00f8rensen S, J\u00f8rgensen FS. Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenat Diagn. 2017, 37:527-39. 10.1002\/pd.5049","journal-title":"Prenat Diagn"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02260","article-title":"Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study","volume":"40","author":"Heesterbeek CJ","year":"2022","unstructured":"Heesterbeek CJ, Aukema SM, Galjaard RH, et al.. Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study. J Clin Oncol. 2022, 40:2426-35. 10.1200\/JCO.21.02260","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00733","article-title":"Prenatal DNA sequencing for fetal aneuploidy also detects maternal cancer: importance of timely workup and management in pregnant women","volume":"40","author":"Turriff AE","year":"2022","unstructured":"Turriff AE, Annunziata CM, Bianchi DW. Prenatal DNA sequencing for fetal aneuploidy also detects maternal cancer: importance of timely workup and management in pregnant women. J Clin Oncol. 2022, 40:2398-401. 10.1200\/JCO.22.00733","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi DW","year":"2015","unstructured":"Bianchi DW, Chudova D, Sehnert AJ, et al.. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA. 2015, 314:162-9. 10.1001\/jama.2015.7120","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-019-0510-5","article-title":"Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests","volume":"21","author":"Ji X","year":"2019","unstructured":"Ji X, Li J, Huang Y, et al.. Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests. Genet Med. 2019, 21:2293-302. 10.1038\/s41436-019-0510-5","journal-title":"Genet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100856","article-title":"Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: a single-center retrospective analysis of over 85,000 pregnancies","volume":"35","author":"Lenaerts L","year":"2021","unstructured":"Lenaerts L, Brison N, Maggen C, et al.. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: a single-center retrospective analysis of over 85,000 pregnancies. EClinicalMedicine. 2021, 35:100856. 10.1016\/j.eclinm.2021.100856","journal-title":"EClinicalMedicine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00429","article-title":"Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model","volume":"5","author":"Dow E","year":"2021","unstructured":"Dow E, Freimund A, Smith K, et al.. Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model. JCO Precis Oncol. 2021, 5:1001-12. 10.1200\/PO.20.00429","journal-title":"JCO Precis Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pd.6031","article-title":"Non-invasive prenatal testing suggesting a maternal malignancy: what do we tell the prospective parents in Belgium?","volume":"41","author":"Lannoo L","year":"2021","unstructured":"Lannoo L, Lenaerts L, Van Den Bogaert K, et al.. Non-invasive prenatal testing suggesting a maternal malignancy: what do we tell the prospective parents in Belgium?. Prenat Diagn. 2021, 41:1264-72. 10.1002\/pd.6031","journal-title":"Prenat Diagn"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-0862-7","article-title":"Pregnancy and cancer: the INCIP project","volume":"22","author":"Maggen C","year":"2020","unstructured":"Maggen C, Wolters VE, Cardonick E, et al.. Pregnancy and cancer: the INCIP project. Curr Oncol Rep. 2020, 22:17. 10.1007\/s11912-020-0862-7","journal-title":"Curr Oncol Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000407","article-title":"Gynecologic malignancies in pregnancy: balancing fetal risks with oncologic safety","volume":"72","author":"Cordeiro CN","year":"2017","unstructured":"Cordeiro CN, Gemignani ML. Gynecologic malignancies in pregnancy: balancing fetal risks with oncologic safety. Obstet Gynecol Surv. 2017, 72:184-93. 10.1097\/OGX.0000000000000407","journal-title":"Obstet Gynecol Surv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5544","article-title":"Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing","volume":"39","author":"Lenaerts L","year":"2019","unstructured":"Lenaerts L, Van Calsteren K, Che H, Vermeesch JR, Amant F. Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing. Prenat Diagn. 2019, 39:1162-5. 10.1002\/pd.5544","journal-title":"Prenat Diagn"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands","volume":"105","author":"van der Meij KR","year":"2019","unstructured":"van der Meij KR, Sistermans EA, Macville MV, et al.. TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands. Am J Hum Genet. 2019, 105:1091-101. 10.1016\/j.ajhg.2019.10.005","journal-title":"Am J Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01101-4","article-title":"Outcome of publicly funded nationwide first-tier noninvasive prenatal screening","volume":"23","author":"Van Den Bogaert K","year":"2021","unstructured":"Van Den Bogaert K, Lannoo L, Brison N, et al.. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med. 2021, 23:1137-42. 10.1038\/s41436-021-01101-4","journal-title":"Genet Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/320894-incidental-diagnosis-of-occult-maternal-malignancy-with-routine-noninvasive-prenatal-testing-during-pregnancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T01:00:17Z","timestamp":1735088417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/320894-incidental-diagnosis-of-occult-maternal-malignancy-with-routine-noninvasive-prenatal-testing-during-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.76331","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,24]]}}}